14/02/2022 - 19:00

Where markets meet medicine; a biotech entrepreneur at the tip of the spear

14/02/2022 - 19:00

Bookmark

Upgrade your subscription to use this feature.

If billionaire “prospector” Mark Creasy has the Midas touch when it comes to divining lucrative mineral deposits, Paul Hopper just might be the man who wields the mythical rod of Asclepius - the Greek God of medicine - when it comes to the equally lucrative ASX-listed biotechnology space. By any measure Hopper has experienced success listing and developing biotech companies on the ASX – and the last year was a good one.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options